RESILIENT BIOTICS, INC.

Profile

Company Names

RESILIENT BIOTICS, INC.

Addresses

2 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC 27709

Phone Numbers

717-350-3133

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$11,034,432.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-08-16 
$3,862,000.00 
$4,600,000.00 
$738,000.00 
Debt 
1
2020-12-02 
$7,172,432.00 
$7,172,432.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPHER 
 
BELNAP 
EXECUTIVE OFFICER, DIRECTOR
RESILIENT BIOTICS, INC.
ERIC 
 
EASON 
DIRECTOR
RESILIENT BIOTICS, INC.
RACHELLE 
 
GALVIN 
EXECUTIVE OFFICER, DIRECTOR
RESILIENT BIOTICS, INC.
DREW 
 
LANZA 
DIRECTOR
AUTONET MOBILE INC   |  R2 SEMICONDUCTOR INC   |  OVERTURE NETWORKS INC   |  BERKELEY CATALYST FUND I LP   |  VALITOR, INC.   |  DNALITE THERAPEUTICS, INC.   |  RESILIENT BIOTICS, INC.   |  BERKELEY CATALYST FUND II LP
JOHN 
 
PERYAM 
DIRECTOR
NANOGUARD TECHNOLOGIES, INC.   |  COVERCRESS INC.   |  RESILIENT BIOTICS, INC.   |  PLASTOMICS INC.   |  FULCRUM GLOBAL CAPITAL FUND II, L.P.
GREG 
 
WERNER 
EXECUTIVE OFFICER, DIRECTOR
RESILIENT BIOTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-12-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-08-16 
2024-09-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-08-16 
2022-08-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-08-16 
2020-12-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#